One of the listed companies, Central Pharmaceuticals Limited discloses its financial reports for the second quarter, (October– December 23).
The company’s earnings per share (EPS) loss Tk 0.09 paisa in Q2 of the current financial year (October – December 23). EPS was loss Tk 0.06 paisa during the same period last year. NAV per share was Tk. 5.44 as of December 31, 2023.
Share this
